Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | 15.82% | $ 11.49M | $ -1.82M |
3/31/2025 | 22.48% | $ 7.77M | $ -1.75M |
12/31/2024 | 15.84% | $ 12.95M | $ -2.05M |
9/30/2024 | 4.76% | $ 43M | $ -2.05M |
6/30/2024 | 7.79% | $ 37.43M | $ -2.92M |
3/31/2024 | 5.12% | $ 62.73M | $ -3.21M |
12/31/2023 | 1.54% | $ 86.82M | $ -1.33M |
9/30/2023 | 0.7% | $ 106.74M | $ -742K |
6/30/2023 | -0.3% | $ 238.89M | $ 719K |
3/31/2023 | -0.41% | $ 227.44M | $ 941K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for CARISMA THERAPEUTICS INC is calculated as follows: (-1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 143.57M ]
(=) Debt Paydown Yield [ 0% ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.28K |
---|---|
min | -11.5% |
max | 11.49% |
average | -0.08% |
median | 0% |
std | 3.82% |